Mirae Asset Global Etfs Holdings Ltd. Dynavax Technologies Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 65,599 shares of DVAX stock, worth $662,549. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,599
Previous 86,421
24.09%
Holding current value
$662,549
Previous $1.12 Million
41.96%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DVAX
# of Institutions
295Shares Held
121MCall Options Held
294KPut Options Held
77.6K-
Black Rock Inc. New York, NY21.9MShares$221 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$180 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$85.1 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$64.6 Million0.0% of portfolio
-
Chicago Capital, LLC5.23MShares$52.8 Million1.29% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.28B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...